Product Code: ETC415111 | Publication Date: Oct 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Australia Codeine market represents a significant segment of the pharmaceutical industry, primarily used as a pain reliever and cough suppressant. However, the market underwent significant changes in recent years due to regulatory measures aimed at addressing concerns regarding misuse and addiction. In 2018, Australia implemented strict regulations requiring a prescription for codeine-containing medications, shifting them from over-the-counter to prescription-only status. This regulatory change had a notable impact on the availability and distribution of codeine products in the country, leading to a decline in sales volume but potentially contributing to improved public health outcomes.
The Australia Codeine market is influenced by several factors. One of the primary drivers is the prevalence of pain-related conditions among the population, leading to the demand for effective pain management solutions. Additionally, factors such as the aging population and increasing healthcare expenditure contribute to the market`s growth. However, regulatory changes, such as the rescheduling of codeine-containing products to prescription-only status, impact market dynamics by altering accessibility and distribution channels. Moreover, public health campaigns and initiatives aimed at addressing opioid misuse and addiction also influence market trends and consumption patterns.
The Australia Codeine market faces several challenges despite its widespread use as a pain reliever and cough suppressant. One significant challenge is the increasing awareness of the addictive properties and potential for misuse and dependency associated with codeine-containing medications. Regulatory restrictions on over-the-counter sales of codeine products have been implemented to address these concerns, posing challenges for manufacturers and distributors in the market. Additionally, healthcare professionals are under pressure to prescribe alternative pain management options, further impacting the demand for codeine-containing medications.
The Australia Codeine market is influenced by government policies aimed at regulating the availability and use of codeine-containing products. In 2018, Australia implemented stricter regulations regarding the sale of codeine-based medications, requiring them to be obtained through prescription rather than over-the-counter. This regulatory change was driven by concerns about the misuse, abuse, and addiction potential of codeine, particularly in combination with other drugs such as paracetamol or ibuprofen. The government`s policy shift towards tighter control over codeine products has had significant implications for manufacturers, distributors, and healthcare professionals involved in the pharmaceutical industry in Australia.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Codeine Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Codeine Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Codeine Market - Industry Life Cycle |
3.4 Australia Codeine Market - Porter's Five Forces |
3.5 Australia Codeine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
4 Australia Codeine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in Australia |
4.2.2 Growing awareness and acceptance of codeine-based medications |
4.2.3 Rising healthcare expenditure and investment in pain management solutions |
4.3 Market Restraints |
4.3.1 Stringent regulatory measures and restrictions on codeine availability |
4.3.2 Concerns over misuse, abuse, and addiction potential of codeine products |
4.3.3 Competition from alternative pain management therapies and medications |
5 Australia Codeine Market Trends |
6 Australia Codeine Market, By Types |
6.1 Australia Codeine Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Codeine Market Revenues & Volume, By Product Type, 2021-2031F |
6.1.3 Australia Codeine Market Revenues & Volume, By Codeine Base, 2021-2031F |
6.1.4 Australia Codeine Market Revenues & Volume, By Codeine Hydrochloride, 2021-2031F |
6.1.5 Australia Codeine Market Revenues & Volume, By Codeine Phosphate, 2021-2031F |
6.1.6 Australia Codeine Market Revenues & Volume, By Other Codeine Salt, 2021-2031F |
7 Australia Codeine Market Import-Export Trade Statistics |
7.1 Australia Codeine Market Export to Major Countries |
7.2 Australia Codeine Market Imports from Major Countries |
8 Australia Codeine Market Key Performance Indicators |
8.1 Number of prescriptions for codeine-based medications |
8.2 Patient satisfaction and reported pain relief levels with codeine treatment |
8.3 Adoption rate of codeine-containing products by healthcare professionals |
9 Australia Codeine Market - Opportunity Assessment |
9.1 Australia Codeine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10 Australia Codeine Market - Competitive Landscape |
10.1 Australia Codeine Market Revenue Share, By Companies, 2024 |
10.2 Australia Codeine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |